Integra LifeSciences IART Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's deferred revenue?
- Integra LifeSciences (IART) reported deferred revenue of $11.62M in Q1 2026.
- How has Integra LifeSciences's deferred revenue changed year-over-year?
- Integra LifeSciences's deferred revenue increased by 10.3% year-over-year, from $10.54M to $11.62M.
- What is the long-term trend for Integra LifeSciences's deferred revenue?
- Over 5 years (2020 to 2025), Integra LifeSciences's deferred revenue has grown at a 16.8% compound annual growth rate (CAGR), from $5.28M to $11.46M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.